Przegląd Gastroenterologiczny

Abstract

2/2015 vol. 10
Review paper

Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection

Prz Gastroenterol 2015; 10 (2): 78–82
Online publish date: 2015/02/10
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Patients with inflammatory bowel disease (IBD) are at risk of developing haemophagocytic lymphohistiocytosis (HLH) because of chronic systemic inflammation as well as exposure to immunosuppressive medications. The two main causes of HLH in IBD patients are infection with cytomegalovirus and Epstein-Barr virus. Patients with Crohn’s disease are more susceptible to HLH than those with ulcerative colitis. The majority of cases are seen in people receiving an immunosuppressive regimen that included thiopurines.
Share
without publication fees